胺碘酮致急性肝衰竭、急性肾衰竭、弥散性血管内凝血1例
A Case of Acute Liver Failure, Acute Renal Failure and Disseminated Intravascular Coagulation Caused by Amiodarone
DOI: 10.12677/ACM.2022.1281074, PDF,   
作者: 吕迎欢:山东济宁医学院临床医学院,山东 济宁;魏明明*:山东济宁医学院附属医院肾内科,山东 济宁
关键词: 胺碘酮急性肝衰竭急性肾衰竭弥散性血管内凝血心房颤动Amiodarone Acute Liver Failure Acute Renal Failure Disseminated Intravascular Coagulation Atrial Fibrillation
摘要: 1例72岁男性患者,因心房颤动入院。住院期间出现短阵室性心动过速,给予胺碘酮片治疗[0.2 g,口服(po),每日三次(TID)],后因快速房颤,加用胺碘酮注射液治疗(首剂150 mg,缓慢静脉注射;之后在16 h 20 min内持续静脉泵入520 mg),1天内出现肝功能衰竭[丙氨酸氨基转移酶(ALT)1821 U/L,天门冬氨酸转移酶(AST) 2260.7 U/L,血糖(Glu) 1.11 mmol/L]、急性肾衰竭[尿素(UREA) 12.18 mmol/L,肌酐(CREA) 163.9 umol/L]、弥散性血管内凝血。停用胺碘酮,加用保肝、血液净化等综合治疗,患者肝功、肾功、凝血功能逐渐恢复。考虑急性肾衰竭、DIC为肝衰竭所致,故采用RUCAM因果关系评估量表,得分为6分,表示急性肝功能衰竭与胺碘酮之间相关性为很可能。
Abstract: A 72-year-old male patient was admitted to the hospital with atrial fibrillation. During his hospital-ization, he developed short-onset ventricular tachycardia and was treated with amiodarone tablets [0.2 g orally (po) three times daily (TID)], followed by amiodarone injection (first dose 150 mg, slow intravenous infusion; followed by continuous intravenous pumping of 520 mg over 16 h 20 min) due to rapid atrial fibrillation, and developed liver failure [alanine aminotransferase (ALT) 1821 U/L, aspartate transferase (AST) 2260.7 U/L, glucose (Glu) 1.11 mmol/L], acute renal failure [urea (UREA) 12.18 mmol/L, creatinine (CREA) 163.9 umol/L], and disseminated intravascular coagula-tion (DIC) within 1 day. Amiodarone was discontinued and a combination of hepatoprotective and hemodialysis treatment was added, and the patient’s liver function, renal function, and coagulation function gradually recovered. Considering acute renal failure and DIC as a result of liver failure, the RUCAM causality assessment scale was used, and the score was 6, indicating that the correlation between acute liver failure and amiodarone was very likely.
文章引用:吕迎欢, 魏明明. 胺碘酮致急性肝衰竭、急性肾衰竭、弥散性血管内凝血1例[J]. 临床医学进展, 2022, 12(8): 7433-7439. https://doi.org/10.12677/ACM.2022.1281074

参考文献

[1] Hindricks, G., Potpara, T., Dagres, N., et al. (2021) 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the Special Contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal, 42, 373-498. [Google Scholar] [CrossRef] [PubMed]
[2] Hashmi, A., Keswani, N.R., Kim, S., et al. (2016) Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone. Southern Medical Journal, 109, 83-86. [Google Scholar] [CrossRef
[3] Mohamed, M., Al-Hillan, A., Flores, M., et al. (2020) Concomitant Acute Hepatic Failure and Renal Failure Induced by Intravenous Amiodarone: A Case Report and Literature Review. Gastroenterology Res, 13, 40-43. [Google Scholar] [CrossRef] [PubMed]
[4] 罗敏, 李思远, 唐尧. 静脉滴注胺碘酮致肝肾功能不全一例及文献分析[J]. 华西医学, 2011, 26(11): 1611-1614.
[5] Cherchi, M., Salmón, Z., Ortiz, F., et al. (2019) Severe Liver Toxicity by Intravenous Amiodarone [Hepatotoxicidad grave por amiodarona Intravenosa]. Medicina Clínica, 153, 258-259. [Google Scholar] [CrossRef] [PubMed]
[6] Jaiswal, P., Attar, B.M., Yap, J.E., et al. (2018) Acute Liver Failure with Amiodarone Infusion: A Case Report and Systematic Review. Journal of Clinical Pharmacy and Therapeu-tics, 43, 129-133. [Google Scholar] [CrossRef] [PubMed]
[7] 杨欣, 袁世加, 周杭, 等. 胺碘酮注射液致急性肝衰竭1例[J]. 中国临床药学杂志, 2022, 31(1): 64-66.
[8] 殷振华, 范莹, 吴硕东. 可达龙致肝功能衰竭、DIC抢救成功一例[J]. 实用药物与临床, 2011, 14(2): 176-177.
[9] 姚咏明, 林洪远, 梁华平, 等. 急危重症病理生理学[M]. 北京: 科学出版社, 2013: 840-841.
[10] 于乐成, 刘鸿凌, 赵新颜, 等. 2021版《ACG临床指南: 特异质性药物性肝损伤的诊断和处理》精粹介绍及相关思考[J]. 肝脏, 2021, 26(5): 465-476.
[11] 熊建群, 高晓波, 何珍, 等. 胺碘酮致肝损害28例文献分析[J]. 中国药业, 2016, 25(3): 90-91.
[12] 毛敏, 徐小华, 赵嘉澍, 等. 60例静脉滴注盐酸胺碘酮致急性肝损害病例分析[J]. 中国药物警戒, 2015, 12(6): 347-351.
[13] Desai, A.D., Chun, S. and Sung, R.J. (1997) The Role of Intravenous Amiodarone in the Management of Cardiac Arrhythmias. Annals of Internal Medicine, 127, 294-303. [Google Scholar] [CrossRef] [PubMed]
[14] Martin 2nd, W.J., Ka-chel, D.L., Vilen, T., et al. (1989) Mechanism of Phospholipidosis in Amiodarone Pulmonary Toxicity. Journal of Pharmacology and Experimental Therapeutics, 251, 272-278.
[15] Kannan, R., Sarma, J.S., Guha, M., et al. (1989) Tissue Drug Accumulation and Ultrastructural Changes during Amiodarone Administration in Rats. Fundamental and Applied Toxicology, 13, 793-803. [Google Scholar] [CrossRef] [PubMed]
[16] Serviddio, G., Bellanti, F., Giudetti, A.M., et al. (2011) Mi-tochondrial Oxidative Stress and Respiratory Chain Dysfunction Account for Liver Toxicity during Amiodarone but Not Dronedarone Administration. Free Radical Biology & Medicine, 51, 2234-2242. [Google Scholar] [CrossRef] [PubMed]
[17] Takai, S., Oda, S., Tsuneyama, K., et al. (2016) Estab-lishment of a Mouse Model for Amiodarone-Induced Liver Injury and Analyses of Its Hepatotoxic Mechanism. Journal of Applied Toxicology, 36, 35-47. [Google Scholar] [CrossRef] [PubMed]
[18] 苏云娟, 宋毓青, 董茜, 等. 静脉应用胺碘酮致急性肝损伤临床病例分析及文献复习[J]. 药物不良反应杂志, 2018, 20(5): 359-365.
[19] Mudalel, M.L., Dave, K.P., Hummel, J.P., et al. (2015) N-Acetylcysteine Treats Intravenous Amiodarone Induced Liver Injury. World Journal of Gastroenterology, 21, 2816-2819. [Google Scholar] [CrossRef] [PubMed]
[20] Wandrer, F., Frangež, Ž., Liebig, S., et al. (2020) Au-tophagy Alleviates Amiodarone-Induced Hepatotoxicity. Archives of Toxicology, 94, 3527-3539. [Google Scholar] [CrossRef] [PubMed]